Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 800 of 923 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 10/11/17
End: 05/31/18
Due: 05/31/19
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 03/07/19
End: 12/03/19
Due: 12/03/20
Phase: N/A
Priority: Normal
Start: 12/23/20
End: 08/30/22
Due: 08/30/23
Phase: N/A
Priority: Normal
Start: 07/31/14
End: 01/31/15
Due: 01/31/16
Phase: N/A
Priority: Normal
Start: 10/16/17
End: 11/10/17
Due: 11/10/18
Phase: N/A
Priority: Normal
Start: 09/05/22
End: 03/31/23
Due: 03/31/24
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 11/30/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/12/22
End: 01/25/23
Due: 01/25/24
Phase: N/A
Priority: Normal
Start: 04/01/18
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 09/02/19
End: 09/23/19
Due: 09/23/20
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 12/31/32
Due: 12/31/33
Phase: N/A
Priority: Normal
Start: 07/13/18
End: 02/28/20
Due: 02/28/21
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 07/19/19
End: 07/18/23
Due: 07/18/24
Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma
Phase: N/A
Priority: Normal
Start: 10/31/04
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 01/02/17
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 08/04/15
End: 08/03/17
Due: 08/03/18